OpenVSafe by OpenVAERS
Search V-safe

7UQ-81682-29483

3 vaccinations 15 coded responses 36 check-ins 15 free-text entries 4 call cases
Sex
Female
Age at first dose
66+
ZIP prefix
222 / VA
Registered
2021-04-30
Relationship
Self
Race
White
Ethnicity
Hispanic or Latino

Timeline

  1. 2021-04-30
    Registered in v-safe
  2. 2021-04-30
    Dose 1 — Pfizer-BioNTech
  3. 2021-04-30
    Health check-in — day 0, dose 1
    Feeling: Good · Fatigue or tiredness · Be unable to work
    Adult check-in
  4. 2021-05-01
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  5. 2021-05-02
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Itching · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work
    Adult check-in
  6. 2021-05-03
    Survey response — days 1–6 daily, dose 1
    MedDRA: Injection site mass, Injection site swelling — Feeling: Fair · Site: Pain, Swelling, Itching · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work
    Free text: Hard lump at injection site more than swollen
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-05-04
    Survey response — days 1–6 daily, dose 1
    MedDRA: Balance disorder, Dizziness — Feeling: Good · Site: Redness, Swelling, Itching · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Over past few days dizziness/ unsteadiness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-05-05
    Survey response — days 1–6 daily, dose 1
    MedDRA: Blood glucose increased, Diabetes mellitus, Pre-existing disease, Type 2 diabetes mellitus — Feeling: Fair · Site: Swelling, Itching · Fatigue or tiredness · Be unable to work
    Free text: Blood sugars have been high DT2
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-05-06
    Survey response — days 1–6 daily, dose 1
    MedDRA: Blood glucose abnormal, Unevaluable event — Feeling: Good · Site: Swelling, Itching · Fatigue or tiredness
    Free text: Blood sugar normal today
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-05-07
    Survey response — day 7, dose 1
    MedDRA: Induration, Pain in extremity, Swelling — Feeling: Good · Fatigue or tiredness
    Free text: Arm still sore to touch and hard lump not swollen
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-05-14
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-05-21
    Dose 2 — Pfizer-BioNTech
  13. 2021-05-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  14. 2021-05-23
    Survey response — days 1–6 daily, dose 2
    MedDRA: Balance disorder — Feeling: Good · Site: Pain, Swelling · Fever · Headache, Muscle or body aches · Be unable to work
    Free text: Losing balance, elevated DT2 blossom sugar
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-05-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Swelling · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work
    Adult check-in
  16. 2021-05-25
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Joint pains
    Adult check-in
  17. 2021-05-26
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  18. 2021-05-27
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Headache
    Adult check-in
  19. 2021-05-30
    Health check-in — day 7, dose 2
    Feeling: Good · Headache, Joint pains, Fatigue or tiredness · Be unable to work
    Adult check-in
  20. 2021-06-04
    Survey response — day 14, dose 2
    MedDRA: Glycosylated haemoglobin increased — Feeling: Good
    Free text: A1C increase
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-06-11
    Survey response — day 21, dose 2
    MedDRA: Pruritus — Feeling: Good
    Free text: Itching
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  22. 2021-06-18
    Survey response — day 28, dose 2
    MedDRA: Nausea, Vomiting — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Nausea; nearly vomiting
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-06-25
    Survey response — day 35, dose 2
    MedDRA: Arrhythmia — Feeling: Fair
    Free text: Arrythmia
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  24. 2021-07-03
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-08-22
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-08-28
    Dose 3 — Pfizer-BioNTech
  27. 2021-08-29
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  28. 2021-08-30
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  29. 2021-08-31
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school
    Adult check-in
  30. 2021-09-01
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Swelling, Itching · Joint pains, Muscle or body aches
    Adult check-in
  31. 2021-09-02
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Itching · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school
    Adult check-in
  32. 2021-09-03
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Itching · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  33. 2021-09-04
    Survey response — day 7, dose 3
    MedDRA: Blood glucose increased, Pre-existing disease — Feeling: Good · Site: Itching · Muscle or body aches, Fatigue or tiredness
    Free text: High blood sugar DT2
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  34. 2021-09-11
    Survey response — day 14, dose 3
    MedDRA: Vertigo — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Vertigo
    MedDRA releases: 2024-11 · check-in free text available
  35. 2021-09-11
    Report sent to call center — day 14, dose 3
    Get care from a doctor or other healthcare professional
    1 call case(s)
  36. 2021-09-15
  37. 2021-09-19
    Health check-in — day 21, dose 3
    Feeling: Fair
    Adult check-in
  38. 2021-09-21
  39. 2021-09-27
    Health check-in — day 28, dose 3
    Feeling: Fair
    Adult check-in
  40. 2021-10-02
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  41. 2021-11-27
    Survey response — 3 months, dose 3
    MedDRA: Faeces soft, Gastrointestinal pain — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: gI cramps soft stools
    MedDRA releases: 2024-11 · check-in free text available
  42. 2021-11-27
    Report sent to call center — 3 months, dose 3
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  43. 2021-11-30
  44. 2021-12-03
    Call successful
    Does not wish to fill out VAERS report
  45. 2022-02-26
    Survey response — 6 months, dose 3
    MedDRA: Extrasystoles, Office visit — Feeling: Fair · Get care from a doctor or other healthcare professional
    Free text: Symptoms: Bigeminy · Healthcare visit (other): Office visit
    MedDRA releases: 2024-11 · check-in free text available
  46. 2022-02-26
    Report sent to call center — 6 months, dose 3
    Get care from a doctor or other healthcare professional
    1 call case(s)
  47. 2022-03-04
  48. 2022-03-09
  49. 2022-08-30
    Survey response — 12 months, dose 3
    MedDRA: Dyspnoea, Fatigue, Gait disturbance, Muscle spasms — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Muscle cramping. Inability To walk and unstable walk, SOB continuing, fatigue continuing
    MedDRA releases: 2024-11 · check-in free text available
  50. 2022-08-30
    Report sent to call center — 12 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  51. 2022-08-31
  52. 2022-08-31

Vaccinations

DoseDateManufacturerCo-administered
12021-04-30Pfizer-BioNTech
22021-05-21Pfizer-BioNTech
32021-08-28Pfizer-BioNTech No

Call center

4 call center cases

2 successful · 2 unsuccessful

See the call center timeline

Free text

Release 8 — days 1–6 daily, dose 1

2021-05-03

Systemic reaction (other): Hard lump at injection site more than swollen

2021-05-04

Systemic reaction (other): Over past few days dizziness/ unsteadiness

2021-05-05

Systemic reaction (other): Blood sugars have been high DT2

2021-05-06

Systemic reaction (other): Blood sugar normal today

Release 8 — day 7, dose 1

2021-05-07

Systemic reaction (other): Arm still sore to touch and hard lump not swollen

Release 8 — days 1–6 daily, dose 2

2021-05-23

Systemic reaction (other): Losing balance, elevated DT2 blossom sugar

Release 8 — day 14, dose 2

2021-06-04

Symptoms: A1C increase

Release 9 — day 21, dose 2

2021-06-11

Symptoms: Itching

Release 9 — day 28, dose 2

2021-06-18

Symptoms: Nausea; nearly vomiting

Release 9 — day 35, dose 2

2021-06-25

Symptoms: Arrythmia

Release 9 — day 7, dose 3

2021-09-04

Systemic reaction (other): High blood sugar DT2

Release 9 — day 14, dose 3

2021-09-11

Symptoms: Vertigo

Release 10 — 3 months, dose 3

2021-11-27

Symptoms: gI cramps soft stools

Release 11 — 6 months, dose 3

2022-02-26

Symptoms: Bigeminy
Healthcare visit (other): Office visit

Release 12 — 12 months, dose 3

2022-08-30

Symptoms: Muscle cramping. Inability To walk and unstable walk, SOB continuing, fatigue continuing

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit · · ✓
SDArrhythmia ✓ ✓ ✓
SDDyspnoea · · ✓
SDExtrasystoles · · ✓
SDFaeces soft · · ✓
SDFatigue · · ✓
SDGait disturbance · · ✓
SDGastrointestinal pain · · ✓
SDGlycosylated haemoglobin increased ✓ ✓ ✓
SDMuscle spasms · · ✓
SDNausea ✓ ✓ ✓
SDPruritus ✓ ✓ ✓
SDVertigo · · ✓
SDVomiting ✓ ✓ ✓
SROBalance disorder ✓ ✓ ✓
SROBlood glucose abnormal ✓ ✓ ○
SROBlood glucose increased ✓ ✓ ✓
SRODiabetes mellitus ✓ ✓ ✓
SRODizziness ✓ ✓ ✓
SROInduration ✓ ✓ ✓
SROInjection site mass ✓ ✓ ✓
SROInjection site swelling ✓ ✓ ✓
SROPain in extremity ✓ ✓ ✓
SROPre-existing disease ✓ ✓ ✓
SROSwelling ✓ ✓ ✓
SROType 2 diabetes mellitus ✓ ✓ ✓
SROUnevaluable event · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release